⌘K
Loading ticker…
As of 2026-08-25, ARS Pharmaceuticals, Inc. Common Stock (SPRY) has a 3-month relative strength percentile of 14 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 37. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.5%, relative volume 0.79×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SPRY is in a stage 4 downtrend, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -19.4% / -34.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
SPRY is held by 19 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $3M notional. Top 3 carry $7M.
Held by 40 ETFs · $71M across latest filings · largest weight 0.57% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $3M | — |
| VTWO | 0.02% | $3M | — |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| SBIO | 0.57% | $928K | −0.02 pp |
| VTWG | 0.03% | $501K | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $436K |
| — |
| ONEQ | 0.00% | $364K | — |
| AVTM | 0.01% | $72K | — |
| IBBQ | 0.07% | $48K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $41K | — |
Showing 10 of 19 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SPRY Jan avg: 0.73% median: -0.46% win: 50% σ: 20.89% n: 4 2022-11-10 → 2026-07-31 | SPRY Feb avg: 9.55% median: 11.46% win: 50% σ: 26.94% n: 4 2022-11-10 → 2026-07-31 | SPRY Mar avg: 0.41% median: 3.28% win: 50% σ: 24.50% n: 4 2022-11-10 → 2026-07-31 | SPRY Apr avg: -0.28% median: 1.35% win: 50% σ: 10.82% n: 4 2022-11-10 → 2026-07-31 | SPRY May avg: 5.56% median: 5.18% win: 100% σ: 3.54% n: 4 2022-11-10 → 2026-07-31 | SPRY Jun avg: 0.34% median: -3.95% win: 25% σ: 14.21% n: 4 2022-11-10 → 2026-07-31 | SPRY Jul avg: 0.70% median: 5.51% win: 75% σ: 26.81% n: 4 2022-11-10 → 2026-07-31 | SPRY Aug avg: -6.13% median: -3.54% win: 33% σ: 26.94% n: 3 2022-11-10 → 2026-07-31 (current) | SPRY Sep avg: -16.16% median: -13.51% win: 33% σ: 29.29% n: 3 2022-11-10 → 2026-07-31 | SPRY Oct avg: -4.96% median: -5.56% win: 33% σ: 6.20% n: 3 2022-11-10 → 2026-07-31 | SPRY Nov avg: 10.75% median: 4.56% win: 75% σ: 16.68% n: 4 2022-11-10 → 2026-07-31 | SPRY Dec avg: 11.36% median: 17.79% win: 75% σ: 27.56% n: 4 2022-11-10 → 2026-07-31 |